HKD 9.17
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.86 Billion CNY | -59.27% |
2022 | 4.61 Billion CNY | 21.19% |
2021 | 3.8 Billion CNY | 140.59% |
2020 | 1.58 Billion CNY | -40.05% |
2019 | 2.64 Billion CNY | -31.67% |
2018 | 3.86 Billion CNY | 43.67% |
2017 | 2.68 Billion CNY | 67.46% |
2016 | 1.6 Billion CNY | 30.9% |
2015 | 1.22 Billion CNY | -4.07% |
2014 | 1.27 Billion CNY | 24.81% |
2013 | 1.02 Billion CNY | -41.32% |
2012 | 1.74 Billion CNY | -54.04% |
2011 | 3.8 Billion CNY | 133.27% |
2010 | 1.62 Billion CNY | 234.26% |
2009 | 634.18 Million CNY | -24.19% |
2008 | 642.87 Million CNY | 74.65% |
2007 | 582.09 Million CNY | 67.89% |
2006 | 219.24 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 1.12 Billion CNY | 0.0% |
2023 Q4 | 772.36 Million CNY | 0.0% |
2023 Q2 | 764.22 Million CNY | 0.0% |
2023 FY | - CNY | -59.27% |
2022 Q4 | 1.85 Billion CNY | 0.0% |
2022 Q2 | 2.75 Billion CNY | 0.0% |
2022 FY | - CNY | 21.19% |
2021 Q4 | 2.5 Billion CNY | 0.0% |
2021 Q2 | 1.3 Billion CNY | 0.0% |
2021 FY | - CNY | 140.59% |
2020 FY | - CNY | -40.05% |
2020 Q4 | 829.2 Million CNY | 0.0% |
2020 Q2 | 753.74 Million CNY | 0.0% |
2019 FY | - CNY | -31.67% |
2019 Q2 | 1.38 Billion CNY | 0.0% |
2019 Q4 | 1.25 Billion CNY | 0.0% |
2018 Q4 | 1.66 Billion CNY | 0.0% |
2018 FY | - CNY | 43.67% |
2018 Q2 | 2.19 Billion CNY | 0.0% |
2017 Q2 | 1.32 Billion CNY | 0.0% |
2017 Q4 | 1.36 Billion CNY | 0.0% |
2017 FY | - CNY | 67.46% |
2016 FY | - CNY | 30.9% |
2016 Q2 | 811.56 Million CNY | 0.0% |
2016 Q4 | 794.77 Million CNY | 0.0% |
2015 Q2 | 357.01 Million CNY | 0.0% |
2015 FY | - CNY | -4.07% |
2015 Q4 | 870.17 Million CNY | 0.0% |
2014 Q4 | 714.71 Million CNY | 0.0% |
2014 Q2 | 272.97 Million CNY | 0.0% |
2014 FY | - CNY | 24.81% |
2013 FY | - CNY | -41.32% |
2013 Q2 | 525.77 Million CNY | 0.0% |
2013 Q4 | 499.15 Million CNY | 0.0% |
2012 Q2 | 438.16 Million CNY | 0.0% |
2012 Q3 | 438.16 Million CNY | 0.0% |
2012 Q4 | 310.1 Million CNY | -29.23% |
2012 Q1 | 438.16 Million CNY | 0.0% |
2012 FY | - CNY | -54.04% |
2011 FY | - CNY | 133.27% |
2011 Q1 | 932.3 Million CNY | 0.0% |
2011 Q2 | 932.3 Million CNY | 0.0% |
2011 Q3 | 932.3 Million CNY | 0.0% |
2011 Q4 | 438.16 Million CNY | -53.0% |
2010 Q1 | 395.36 Million CNY | 0.0% |
2010 FY | - CNY | 234.26% |
2010 Q4 | 932.3 Million CNY | 135.81% |
2010 Q3 | 395.36 Million CNY | 0.0% |
2010 Q2 | 395.36 Million CNY | 0.0% |
2009 FY | - CNY | -24.19% |
2009 Q4 | 395.36 Million CNY | 197.23% |
2009 Q3 | 133.01 Million CNY | 0.0% |
2009 Q2 | 133.01 Million CNY | 0.0% |
2009 Q1 | 133.01 Million CNY | 0.0% |
2008 Q4 | 133.01 Million CNY | -14.9% |
2008 Q2 | 156.31 Million CNY | 0.0% |
2008 Q1 | 156.31 Million CNY | 0.0% |
2008 Q3 | 156.31 Million CNY | 0.0% |
2008 FY | - CNY | 74.65% |
2007 Q1 | 72.78 Million CNY | 0.0% |
2007 Q4 | 156.31 Million CNY | 114.76% |
2007 FY | - CNY | 67.89% |
2007 Q3 | 72.78 Million CNY | 0.0% |
2007 Q2 | 72.78 Million CNY | 0.0% |
2006 Q2 | 39.64 Million CNY | 0.0% |
2006 Q1 | 39.64 Million CNY | 0.0% |
2006 FY | - CNY | 0.0% |
2006 Q4 | 72.78 Million CNY | 83.58% |
2006 Q3 | 39.64 Million CNY | 0.0% |
2005 Q4 | 39.64 Million CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Wai Chun Bio-Technology Limited | 14.89 Million HKD | -12450.386% |
Lee & Man Chemical Company Limited | 597.01 Million HKD | -213.078% |